Global Targeted Drugs for Huntington's Disease Market Growth (Status and Outlook) 2026-2032

February 2026 | 71 pages | ID: GC03553C2C4EEN
LP Information

Abstracts

The global Targeted Drugs for Huntington's Disease market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Targeted Drugs for Huntington's Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Targeted Drugs for Huntington's Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Targeted Drugs for Huntington's Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Targeted Drugs for Huntington's Disease players cover Neurocrine, Lundbeck, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Targeted Drugs for Huntington's Disease Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Huntington's Disease sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Huntington's Disease sales for 2026 through 2032. With Targeted Drugs for Huntington's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Huntington's Disease industry.

This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Huntington's Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for Huntington's Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Huntington's Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Huntington's Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Huntington's Disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Huntington's Disease market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Pill
• Capsule

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Neurocrine
• Lundbeck
• Teva

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Targeted Drugs for Huntington's Disease Market Size (2021-2032)
  2.1.2 Targeted Drugs for Huntington's Disease Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Targeted Drugs for Huntington's Disease by Country/Region (2021, 2025 & 2032)
2.2 Targeted Drugs for Huntington's Disease Segment by Type
  2.2.1 Pill
  2.2.2 Capsule
  2.2.3 Targeted Drugs for Huntington's Disease Market Size by Type
    2.2.3.1 Targeted Drugs for Huntington's Disease Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Targeted Drugs for Huntington's Disease Market Size Market Share by Type (2021-2026)
2.3 Targeted Drugs for Huntington's Disease Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Targeted Drugs for Huntington's Disease Market Size by Application
    2.3.4.1 Targeted Drugs for Huntington's Disease Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Targeted Drugs for Huntington's Disease Market Size Market Share by Application (2021-2026)

3 TARGETED DRUGS FOR HUNTINGTON'S DISEASE MARKET SIZE BY PLAYER

3.1 Targeted Drugs for Huntington's Disease Market Size Market Share by Player
  3.1.1 Global Targeted Drugs for Huntington's Disease Revenue by Player (2021-2026)
  3.1.2 Global Targeted Drugs for Huntington's Disease Revenue Market Share by Player (2021-2026)
3.2 Global Targeted Drugs for Huntington's Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TARGETED DRUGS FOR HUNTINGTON'S DISEASE BY REGION

4.1 Targeted Drugs for Huntington's Disease Market Size by Region (2021-2026)
4.2 Global Targeted Drugs for Huntington's Disease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Drugs for Huntington's Disease Market Size Growth (2021-2026)
4.4 APAC Targeted Drugs for Huntington's Disease Market Size Growth (2021-2026)
4.5 Europe Targeted Drugs for Huntington's Disease Market Size Growth (2021-2026)
4.6 Middle East & Africa Targeted Drugs for Huntington's Disease Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Targeted Drugs for Huntington's Disease Market Size by Country (2021-2026)
5.2 Americas Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026)
5.3 Americas Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Targeted Drugs for Huntington's Disease Market Size by Region (2021-2026)
6.2 APAC Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026)
6.3 APAC Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Targeted Drugs for Huntington's Disease Market Size by Country (2021-2026)
7.2 Europe Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026)
7.3 Europe Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Targeted Drugs for Huntington's Disease by Region (2021-2026)
8.2 Middle East & Africa Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026)
8.3 Middle East & Africa Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TARGETED DRUGS FOR HUNTINGTON'S DISEASE MARKET FORECAST

10.1 Global Targeted Drugs for Huntington's Disease Forecast by Region (2027-2032)
  10.1.1 Global Targeted Drugs for Huntington's Disease Forecast by Region (2027-2032)
  10.1.2 Americas Targeted Drugs for Huntington's Disease Forecast
  10.1.3 APAC Targeted Drugs for Huntington's Disease Forecast
  10.1.4 Europe Targeted Drugs for Huntington's Disease Forecast
  10.1.5 Middle East & Africa Targeted Drugs for Huntington's Disease Forecast
10.2 Americas Targeted Drugs for Huntington's Disease Forecast by Country (2027-2032)
  10.2.1 United States Market Targeted Drugs for Huntington's Disease Forecast
  10.2.2 Canada Market Targeted Drugs for Huntington's Disease Forecast
  10.2.3 Mexico Market Targeted Drugs for Huntington's Disease Forecast
  10.2.4 Brazil Market Targeted Drugs for Huntington's Disease Forecast
10.3 APAC Targeted Drugs for Huntington's Disease Forecast by Region (2027-2032)
  10.3.1 China Targeted Drugs for Huntington's Disease Market Forecast
  10.3.2 Japan Market Targeted Drugs for Huntington's Disease Forecast
  10.3.3 Korea Market Targeted Drugs for Huntington's Disease Forecast
  10.3.4 Southeast Asia Market Targeted Drugs for Huntington's Disease Forecast
  10.3.5 India Market Targeted Drugs for Huntington's Disease Forecast
  10.3.6 Australia Market Targeted Drugs for Huntington's Disease Forecast
10.4 Europe Targeted Drugs for Huntington's Disease Forecast by Country (2027-2032)
  10.4.1 Germany Market Targeted Drugs for Huntington's Disease Forecast
  10.4.2 France Market Targeted Drugs for Huntington's Disease Forecast
  10.4.3 UK Market Targeted Drugs for Huntington's Disease Forecast
  10.4.4 Italy Market Targeted Drugs for Huntington's Disease Forecast
  10.4.5 Russia Market Targeted Drugs for Huntington's Disease Forecast
10.5 Middle East & Africa Targeted Drugs for Huntington's Disease Forecast by Region (2027-2032)
  10.5.1 Egypt Market Targeted Drugs for Huntington's Disease Forecast
  10.5.2 South Africa Market Targeted Drugs for Huntington's Disease Forecast
  10.5.3 Israel Market Targeted Drugs for Huntington's Disease Forecast
  10.5.4 Turkey Market Targeted Drugs for Huntington's Disease Forecast
10.6 Global Targeted Drugs for Huntington's Disease Forecast by Type (2027-2032)
10.7 Global Targeted Drugs for Huntington's Disease Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Targeted Drugs for Huntington's Disease Forecast

11 KEY PLAYERS ANALYSIS

11.1 Neurocrine
  11.1.1 Neurocrine Company Information
  11.1.2 Neurocrine Targeted Drugs for Huntington's Disease Product Offered
  11.1.3 Neurocrine Targeted Drugs for Huntington's Disease Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Neurocrine Main Business Overview
  11.1.5 Neurocrine Latest Developments
11.2 Lundbeck
  11.2.1 Lundbeck Company Information
  11.2.2 Lundbeck Targeted Drugs for Huntington's Disease Product Offered
  11.2.3 Lundbeck Targeted Drugs for Huntington's Disease Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Lundbeck Main Business Overview
  11.2.5 Lundbeck Latest Developments
11.3 Teva
  11.3.1 Teva Company Information
  11.3.2 Teva Targeted Drugs for Huntington's Disease Product Offered
  11.3.3 Teva Targeted Drugs for Huntington's Disease Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Teva Main Business Overview
  11.3.5 Teva Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Targeted Drugs for Huntington's Disease Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Drugs for Huntington's Disease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pill
Table 4. Major Players of Capsule
Table 5. Targeted Drugs for Huntington's Disease Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Targeted Drugs for Huntington's Disease Market Size Market Share by Type (2021-2026)
Table 8. Targeted Drugs for Huntington's Disease Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Targeted Drugs for Huntington's Disease Market Size Market Share by Application (2021-2026)
Table 11. Global Targeted Drugs for Huntington's Disease Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Targeted Drugs for Huntington's Disease Revenue Market Share by Player (2021-2026)
Table 13. Targeted Drugs for Huntington's Disease Key Players Head office and Products Offered
Table 14. Targeted Drugs for Huntington's Disease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Targeted Drugs for Huntington's Disease Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Targeted Drugs for Huntington's Disease Market Size Market Share by Region (2021-2026)
Table 19. Global Targeted Drugs for Huntington's Disease Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Targeted Drugs for Huntington's Disease Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Targeted Drugs for Huntington's Disease Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Targeted Drugs for Huntington's Disease Market Size Market Share by Country (2021-2026)
Table 23. Americas Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Targeted Drugs for Huntington's Disease Market Size Market Share by Type (2021-2026)
Table 25. Americas Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Targeted Drugs for Huntington's Disease Market Size Market Share by Application (2021-2026)
Table 27. APAC Targeted Drugs for Huntington's Disease Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Targeted Drugs for Huntington's Disease Market Size Market Share by Region (2021-2026)
Table 29. APAC Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Targeted Drugs for Huntington's Disease Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Targeted Drugs for Huntington's Disease Market Size Market Share by Country (2021-2026)
Table 33. Europe Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Targeted Drugs for Huntington's Disease
Table 39. Key Market Challenges & Risks of Targeted Drugs for Huntington's Disease
Table 40. Key Industry Trends of Targeted Drugs for Huntington's Disease
Table 41. Global Targeted Drugs for Huntington's Disease Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Targeted Drugs for Huntington's Disease Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Targeted Drugs for Huntington's Disease Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Targeted Drugs for Huntington's Disease Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Neurocrine Details, Company Type, Targeted Drugs for Huntington's Disease Area Served and Its Competitors
Table 46. Neurocrine Targeted Drugs for Huntington's Disease Product Offered
Table 47. Neurocrine Targeted Drugs for Huntington's Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Neurocrine Main Business
Table 49. Neurocrine Latest Developments
Table 50. Lundbeck Details, Company Type, Targeted Drugs for Huntington's Disease Area Served and Its Competitors
Table 51. Lundbeck Targeted Drugs for Huntington's Disease Product Offered
Table 52. Lundbeck Targeted Drugs for Huntington's Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Lundbeck Main Business
Table 54. Lundbeck Latest Developments
Table 55. Teva Details, Company Type, Targeted Drugs for Huntington's Disease Area Served and Its Competitors
Table 56. Teva Targeted Drugs for Huntington's Disease Product Offered
Table 57. Teva Targeted Drugs for Huntington's Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Teva Main Business
Table 59. Teva Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Targeted Drugs for Huntington's Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for Huntington's Disease Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Drugs for Huntington's Disease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Drugs for Huntington's Disease Sales Market Share by Country/Region (2025)
Figure 8. Targeted Drugs for Huntington's Disease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Drugs for Huntington's Disease Market Size Market Share by Type in 2025
Figure 10. Targeted Drugs for Huntington's Disease in Hospital
Figure 11. Global Targeted Drugs for Huntington's Disease Market: Hospital (2021-2026) & ($ millions)
Figure 12. Targeted Drugs for Huntington's Disease in Clinic
Figure 13. Global Targeted Drugs for Huntington's Disease Market: Clinic (2021-2026) & ($ millions)
Figure 14. Targeted Drugs for Huntington's Disease in Other
Figure 15. Global Targeted Drugs for Huntington's Disease Market: Other (2021-2026) & ($ millions)
Figure 16. Global Targeted Drugs for Huntington's Disease Market Size Market Share by Application in 2025
Figure 17. Global Targeted Drugs for Huntington's Disease Revenue Market Share by Player in 2025
Figure 18. Global Targeted Drugs for Huntington's Disease Market Size Market Share by Region (2021-2026)
Figure 19. Americas Targeted Drugs for Huntington's Disease Market Size 2021-2026 ($ millions)
Figure 20. APAC Targeted Drugs for Huntington's Disease Market Size 2021-2026 ($ millions)
Figure 21. Europe Targeted Drugs for Huntington's Disease Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size 2021-2026 ($ millions)
Figure 23. Americas Targeted Drugs for Huntington's Disease Value Market Share by Country in 2025
Figure 24. United States Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Targeted Drugs for Huntington's Disease Market Size Market Share by Region in 2025
Figure 29. APAC Targeted Drugs for Huntington's Disease Market Size Market Share by Type (2021-2026)
Figure 30. APAC Targeted Drugs for Huntington's Disease Market Size Market Share by Application (2021-2026)
Figure 31. China Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 35. India Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Targeted Drugs for Huntington's Disease Market Size Market Share by Country in 2025
Figure 38. Europe Targeted Drugs for Huntington's Disease Market Size Market Share by Type (2021-2026)
Figure 39. Europe Targeted Drugs for Huntington's Disease Market Size Market Share by Application (2021-2026)
Figure 40. Germany Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 41. France Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Targeted Drugs for Huntington's Disease Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 54. APAC Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 55. Europe Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 57. United States Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 58. Canada Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 59. Mexico Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 60. Brazil Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 61. China Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 62. Japan Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 63. Korea Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 65. India Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 66. Australia Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 67. Germany Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 68. France Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 69. UK Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 70. Italy Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 71. Russia Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 72. Egypt Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 73. South Africa Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 74. Israel Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 75. Turkey Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)
Figure 76. Global Targeted Drugs for Huntington's Disease Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Targeted Drugs for Huntington's Disease Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Targeted Drugs for Huntington's Disease Market Size 2027-2032 ($ millions)